The ancient use of mushrooms to improve physical and mental well-being is coming back full-swing. On Monday, Lucy Scientific Discovery Inc. unveiled Mindful, a functional Amanita mushroom-based product line that is now available at multiple retailers.
British Columbia, Canada-based Lucy Scientific Discovery is a psychedelics manufacturing company focused primarily on emerging psychotropics-based medicines, the latest being its new microdose product line.
Mindful by Lucy is designed to enhance well-being and promote a mindful approach through the power of microdoses. Each capsule is carefully crafted, incorporating quality natural ingredients. Mindful by Lucy comes in jars of 60 capsules containing a microdose of Amanita muscaria-based compounds.
“We are thrilled that Mindful will be available to consumers, and are excited about the revenue potential,” said Chris McElvany, CEO of Lucy Scientific Discovery Inc. “Our goal is to offer Mindful to consumers directly through our platform and a variety of 3rd party platforms and traditional retail channels. Mindful by Lucy is a testament to our dedication to providing exceptional quality and a mindful approach to wellness.”
A recent renewed interest in the potential improvements in cognitive function and memory with the help of mushrooms is sweeping the industry, using them as adaptogens. Dividing up doses into capsules makes it easier to titrate. Mindful by Lucy contains ingredients, some mushroom-based, including the following:
- Lion’s Mane Mushroom: Ignite cognitive function, memory, and nerve growth factor production.
- Reishi Mushroom: Adapt to stress and bolster well-being with adaptogenic properties.
- Cordyceps: Elevate energy levels and amplify physical performance.
- Bacopa Monnieri: Boost memory and learning with traditional Ayurvedic wisdom.
- Rhodiola Rosea: Combat stress, fatigue, and sharpen mental performance.
- Ginkgo Biloba: Enhance memory and focus through optimal brain circulation.
Lucy Scientific Discovery and Psychotropic Products
Lucy Scientific Discovery has explored a number of psychotropic substances including controlled substances. How is this possible? The company holds a Controlled Drugs and Substances Dealer’s License granted by Health Canada’s Office of Controlled Substances. Lucy Scientific Discovery and its subsidiary, LSDI Manufacturing Inc., operate under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act in Canada. This specialized license enables the company to develop, sell, deliver, and manufacture pharmaceutical-grade active pharmaceutical ingredients (APIs) used in controlled substances as well as their raw material precursors.
The Amanita muscaria mushroom has been used medicinally for hundreds of years, and it is not a controlled substance in the U.S. Proponents of Amanita microdosing believe that it can improve creativity, focus, productivity, anxiety and overall well-being.
The company is exploring other types of fungi as well, including mind-altering varieties that are commonly known. Work at Lucy is underway to develop psilocybin mushroom-based products which are believed to be invaluable in psychotherapy. Lucy Scientific Discovery announced a partnership with TheraPsil to advance medical psilocybin access and research.
Opportunities to discover these new products are approaching. Lucy Scientific Discovery also announced that it will be a sponsor at the Multidisciplinary Association for Psychedelic Studies (MAPS) Psychedelic Science Conference taking place June 19-25 in Denver, Colorado.
The conference is expected to attract 10,000 attendees, and will feature five days of panels, workshops, and lectures from leaders in psychedelic research, education, policy, business, culture, and communities. It will also feature athletes such as Aaron Rodgers as well as musicians including Melissa Etheridge.